PDF(Pubmed)
Abstract：
The Zambia Immunisation Technical Advisory Group (ZITAG) was established in 2016 as an advisory body to provide evidence-based recommendations on vaccine policy. As part of the Gave Full Country Evaluation, we evaluated the functionality and effectiveness of ZITAG and related EPI committees through an online stakeholder survey of Interagnecy Coordinating Committee (ICC), ZITAG and Extended programme on Immunisation Technical Working Group (EPI-TWG) members, document review and key informant interviews. The survey was sent out via SurveyMonkey between May and July 2020 to 69 members of ZITAG, ICC or the EPI TWG. A total of 52 individuals responded (75%). Eight key informant interviews were also carried out at the national and global level in September 2020 to elaborate further on some of the quantitative findings and for triangulation. Findingsrevealed that the EPI committees were reasonably functional and effective entities, each with its unique role, though some overlaps occurred. Functionality was shown by having a broad membership with wide expertise and long-serving members; sub-committees existed and meetings were occurring regularly. Leadership and coordination structures also existed and were largely felt to be working well. Funding challenges however persisted, in particular for ZITAG operations and functionality of its subcommittees. Effectiveness and value addition fo the committees to the EPI was illustrated through decision-making processes and evidence use as well as relatively good country ownership in terms of commitment, legitimacy, capacity and accountability. Full independence and ownership may however be compromised by funding challenges. Recent changes to ICC terms of reference and focus beyond immunisation side-lined the EPI and weakened the linkage between ICC and ZITAG with many ZITAG recommendations not having been followed through by ICC as the ultimate endorsing entity.
摘要：
赞比亚免疫技术咨询组（ZITAG）成立于2016年，是一个咨询机构，旨在就疫苗政策提供循证建议。作为全面国家评估的一部分，我们通过内部协调委员会（ICC）的在线利益相关者调查评估了ZITAG和相关EPI委员会的功能和有效性，ZITAG和扩展计划免疫技术工作组（EPI-TWG）成员，文件审查和关键线人访谈。该调查于2020年5月至7月通过SurveyMonkey发送给ZITAG的69名成员，ICC或EPITWG。共有52人回答（75％）。2020年9月，还在国家和全球层面进行了八次关键线人访谈，以进一步阐述一些定量结果和三角测量。调查结果显示，扩大免疫方案委员会是合理运作和有效的实体，每个人都有其独特的角色，尽管发生了一些重叠。具有广泛的成员，广泛的专业知识和长期服务的成员显示了功能；存在小组委员会，并定期举行会议。领导和协调结构也存在，基本上被认为运作良好。然而，资金挑战依然存在，特别是ZITAG的运营和其小组委员会的职能。通过决策过程和证据使用以及在承诺方面相对良好的国家所有权，说明了委员会对扩大免疫方案的有效性和附加值，合法性,能力和问责制。然而，完全的独立性和所有权可能会因资金挑战而受到损害。最近对国际刑事法院职权范围和免疫接种以外的重点的变化使扩大免疫方案处于次要地位，并削弱了国际刑事法院与ZITAG之间的联系，国际刑事法院作为最终认可实体没有遵循ZITAG的许多建议。
